Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

37.07 +0.76 (+2.09%)

Official Closing Price Updated: 7:00 PM EST, Dec 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

48 49 Next >

Can Hims & Hers Keep Its GLP-1 Edge After Trump Forces Lilly And Novo To Slash Prices? Wall Street Isn’t Convinced ↗

November 06, 2025

Citi calls Trump’s GLP-1 pricing deal “less bad than feared,” while Needham warns it could erode Hims’ cost advantage.

Via Stocktwits

Topics Government World Trade

Eli Lilly, Novo Nordisk Or A Dark Horse: Which Obesity-Drug Stock Are Retail Traders Most Bullish On Over Next 5 Years? ↗

November 06, 2025

Via Stocktwits

1 Growth Stock to Stash and 2 We Ignore

November 05, 2025

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

Via StockStory

Why Are Hims & Hers Health (HIMS) Shares Soaring Today

November 05, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 6.9% in the morning session after the company reported third-quarter 2025 results that showed strong revenue growth, even as its...

Via StockStory

Hims & Hers Q3 Preview: GLP-1 Drug Expansion Draws Investor Focus ↗

November 03, 2025

Via Stocktwits

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

Why Hims & Hers Stock May Be a Buy After Mixed Q3 Results ↗

November 05, 2025

Via MarketBeat

HIMS CEO Says 'A Little Bit of Craziness' Is The Secret To Building A Global Health Platform ↗

November 04, 2025

Hims & Hers Health (HIMS) CEO Andrew Dudum, sees potential for emotional and medical transformation and plans for global expansion.

Via Benzinga

HIMS Q3 Deep Dive: Personalized Offerings and Strategic Expansion Shape Telehealth Growth

November 04, 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 49.2% year on year to $599 million. On the other hand, next...

Via StockStory

Hims & Hers Health Stock Jumps After-Hours As Q3 Growth, Novo Nordisk Talks Fuel Bullish Retail Bets ↗

November 03, 2025

Revenue rose 49% year-over-year to nearly $600 million, while net income reached $15.8 million and adjusted EBITDA climbed 53% to $78.4 million.

Via Stocktwits

Topics Earnings

Palantir, Kimberly-Clark, Hims & Hers, Navitas And Cipher Mining: Why These 5 Stocks Are On Investors' Radars Today ↗

November 03, 2025

PLTR, KMB, HIMS, NVTS, CIFR were among the stocks seen trending among investors on Monday, Nov. 3, 2025.

Via Benzinga

Hims Hers (HIMS) Q3 2025 Earnings Call Transcript ↗

November 03, 2025

Hims Hers (HIMS) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Hims & Hers Health (HIMS) Surges After Hours on Robust Q3 and Renewed Novo Nordisk (NVO) Wegovy Talks

November 03, 2025

Hims & Hers Health (NYSE: HIMS) became a significant after-hours mover on Monday, November 3, 2025, following the release of its third-quarter 2025 financial results and the pivotal announcement of...

Via MarketMinute

Topics Artificial Intelligence Economy

Hims Says It's Negotiating A New Deal With Novo Nordisk; Shares Surge ↗

November 03, 2025

Hims & Hers Health said late Monday it's in discussions with Novo Nordisk to sell Wegovy shots. The news buoyed Hims stock.

Via Investor's Business Daily

Hims & Hers Stock Pops After Q3 Earnings: Here's Why ↗

November 03, 2025

Here's a look at the Q3 earnings report from Hims & Hers Health.

Via Benzinga

Hims & Hers Health’s (NYSE:HIMS) Q3 Sales Top Estimates

November 03, 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 49.2% year on year to $599 million. On the other hand, next...

Via StockStory

Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results

November 03, 2025

From Hims & Hers

Via Business Wire

Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗

November 03, 2025

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.

Via Benzinga

Stock Market Today: S&P 500, Dow Jones Futures Rise After Stellar October Gains— Micron Tech, Palantir, Hims & Hers In Focus ↗

November 03, 2025

U.S. stock futures advanced on Monday after Friday’s positive moves. Futures of major benchmark indices were higher.

Via Benzinga

Topics Stocks

Hims & Hers Health (HIMS) Q3 Earnings: What To Expect

November 01, 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings this Monday afternoon. Here’s what you need to know.

Via StockStory

Why Hims & Hers Health (HIMS) Stock Is Trading Up Today

October 31, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.4% in the afternoon session after JPMorgan Chase & Co. disclosed in a regulatory filing that it had taken a significant passive...

Via StockStory

10 Health Care Stocks Whale Activity In Today's Session ↗

October 30, 2025

Via Benzinga

1 Profitable Stock on Our Watchlist and 2 We Find Risky

October 29, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

Topics Retirement

Hims & Hers Short Interest Nears All-Time High, Buy The Dip? ↗

October 24, 2025

Hims & Hers stock is falling well off its 52-week highs, as bears lean on the CEO's scheduled sale that just took place, though it might be a mistake.

Via MarketBeat

1 Mid-Cap Stock Worth Your Attention and 2 We Avoid

October 23, 2025

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...

Via StockStory

Looking For The Next Beyond Meat? Here Are The Top 10 Most Shorted Stocks ↗

October 22, 2025

Here's a look at the most heavily shorted stocks in the market as investors look for the next Beyond Meat.

Via Benzinga

Short Squeeze Frenzy Fuels October's Market Rebound: A Closer Look at Bearish Bets and Bullish Surges

October 21, 2025

The U.S. stock market has staged a remarkable recovery in October 2025, with major indices reclaiming lost ground amidst a confluence of positive corporate earnings and improving macroeconomic...

Via MarketMinute

Topics Economy Stocks World Trade

This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

October 21, 2025

Via Benzinga

Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know

October 20, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.9% in the morning session after investors looked past a recent insider stock sale and focused on the company's strong growth...

Via StockStory

Benzinga Bulls And Bears: Stellantis, Papa John's, Oklo — And Trade Tensions Shake Chip Stocks ↗

October 18, 2025

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Via Benzinga

Topics World Trade

< Previous 1 2 3 4 5 6 7 8 9

...

48 49 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

All News about Hims & Hers Health, Inc. Class A Common Stock

Starting at $3.75/week.

Subscribe Today